Northern Trust
INMB icon

Northern Trust’s INmune Bio INMB Stock Holding History

Northern Trust’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208K Buy
184,225
+8,576
+5% +$12.2K ﹤0.01% 3936
2025
Q4 		$274K Sell
175,649
-13,467
-7% -$24K ﹤0.01% 3866
2025
Q3 		$391K Buy
189,116
+24,699
+15% +$56.5K ﹤0.01% 3736
2025
Q2 		$380K Buy
164,417
+11,972
+8% +$87.9K ﹤0.01% 3739
2025
Q1 		$1.19M Buy
152,445
+46,484
+44% +$369K ﹤0.01% 3203
2024
Q4 		$495K Buy
105,961
+9,154
+9% +$47.7K ﹤0.01% 3661
2024
Q3 		$522K Buy
96,807
+68,748
+245% +$489K ﹤0.01% 3572
2024
Q2 		$247K Buy
28,059
+7,642
+37% +$75.3K ﹤0.01% 3783
2024
Q1 		$240K Sell
20,417
-4,652
-19% -$56.2K ﹤0.01% 3834
2023
Q4 		$282K Buy
25,069
+4,799
+24% +$40.2K ﹤0.01% 3752
2023
Q3 		$137K Hold
20,270
– – ﹤0.01% 3933
2023
Q2 		$184K Sell
20,270
-27
-0.1% -$217 ﹤0.01% 3859
2023
Q1 		$131K Buy
20,297
+1,191
+6% +$9.59K ﹤0.01% 4007
2022
Q4 		$121K Hold
19,106
– – ﹤0.01% 4029
2022
Q3 		$118K Hold
19,106
– – ﹤0.01% 4061
2022
Q2 		$169K Sell
19,106
-799
-4% -$5.95K ﹤0.01% 3987
2022
Q1 		$168K Hold
19,905
– – ﹤0.01% 4190
2021
Q4 		$203K Sell
19,905
-2,316
-10% -$34.3K ﹤0.01% 4190
2021
Q3 		$432K Buy
22,221
+8,272
+59% +$160K ﹤0.01% 3818
2021
Q2 		$245K Hold
13,949
– – ﹤0.01% 4065
2021
Q1 		$166K Buy
13,949
+1,575
+13% +$28.4K ﹤0.01% 4159
2020
Q4 		$213K Buy
+12,374
New +$117K ﹤0.01% 3946

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Northern Trust's INMB Position: Q1 2026 in Review

Northern Trust increased its INmune Bio (INMB) stake by 4.9% in Q1 2026, buying an estimated $12.2K and bringing the position to 184,225 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #3936.

Northern Trust first reported a position in INMB in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.19M in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Northern Trust held 184,225 shares of INmune Bio worth $208K as of Q1 2026.
  • Northern Trust bought 8,576 INmune Bio shares in Q1 2026, an estimated $12.2K.
  • INmune Bio made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3936 holding.
  • Northern Trust first reported a position in INmune Bio in Q4 2020 and has held it in 22 quarters since.
  • Northern Trust's INmune Bio position peaked at $1.19M in Q1 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.